Contrasting PACS Group (PACS) and Its Peers

PACS Group (NYSE:PACS) is one of 233 public companies in the “Healthcare Providers & Services” industry, but how does it contrast to its rivals? We will compare PACS Group to related businesses based on the strength of its analyst recommendations, profitability, valuation, earnings, dividends, risk and institutional ownership.

Profitability

This table compares PACS Group and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
PACS Group	4.87%	31.98%	6.07%
PACS Group Competitors	-8.06%	-138.13%	-1.54%

Analyst Recommendations

This is a summary of recent ratings and target prices for PACS Group and its rivals, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PACS Group	0	1	7	0	2.88
PACS Group Competitors	1867	7741	13367	825	2.55

PACS Group currently has a consensus target price of $61.33, suggesting a potential upside of 22.36%. As a group, “Healthcare Providers & Services” companies have a potential upside of 12.66%. Given PACS Group’s stronger consensus rating and higher probable upside, equities analysts clearly believe PACS Group is more favorable than its rivals.

Institutional and Insider Ownership

56.7% of shares of all “Healthcare Providers & Services” companies are owned by institutional investors. 70.1% of PACS Group shares are owned by company insiders. Comparatively, 15.0% of shares of all “Healthcare Providers & Services” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Valuation and Earnings

This table compares PACS Group and its rivals revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
PACS Group	$5.29 billion	$191.54 million	28.32
PACS Group Competitors	$21.55 billion	$301.67 million	7.21

PACS Group’s rivals have higher revenue and earnings than PACS Group. PACS Group is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Risk and Volatility

PACS Group has a beta of -0.14, indicating that its stock price is 114% less volatile than the S&P 500. Comparatively, PACS Group’s rivals have a beta of 0.98, indicating that their average stock price is 2% less volatile than the S&P 500.

Summary

PACS Group beats its rivals on 8 of the 13 factors compared.

PACS Group Company Profile

PACS Group, Inc. is a post-acute healthcare provider that operates skilled nursing and rehabilitation facilities. Its services include nursing care, physical and occupational therapy, and support for patients recovering from illness or injury, as well as care for people with ongoing or long-term needs. Founded in 2013, the company has expanded its network of facilities across the United States. Its operations are organized through affiliated entities, with care and services tailored to the needs of residents and patients in the communities it serves.